
Home » Prescription Drugs 3 » BONMAX Evista
Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures.Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause.This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen receptor modulator or SERM) in some parts of the body. Raloxifene helps to preserve bone mass but it does not affect the breast and uterus like estrogen or relieve symptoms of menopause such as hot flashes.This medication is not recommended for use in women before menopause. It should not be used in children.This medication should not be used to prevent heart disease.How to use Raloxifene OralTake this medication by mouth usually once a day with or without food or as directed by your doctor. Use this medication regularly to get the most benefit from it. Remember to use it at the same time each day.Be sure to include adequate amounts of calcium and vitamin D in your diet. Consult your doctor or pharmacist to see if you need to take calcium/vitamin D supplements.
Buy BONMAX Evista and other Prescription Drugs 3 products online
at Medstore.
330 Buy Online at Medstore - Click Here!

About BONMAX Evista:
Product Type: Prescription Drugs 3
BONMAX ( Evista Generic Raloxifene )
BONMAX (Evista Generic Raloxifene)
Evista Generic Raloxifene
60mg 28 (4 x 7)
Evista Generic Raloxifene BONMAX

View more
Prescription Drugs 3
Previous Product Next Product
Pharmacy:
Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide:
Which drugs are scheduled to go generic?
Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.


|